KLOW is an advanced four-peptide blend that builds upon the GLOW formulation (GHK-Cu, BPC-157, TB-500) with the addition of KPV (Lysine-Proline-Valine) — a tripeptide with a dedicated anti-inflammatory mechanism . The name “KLOW” is an informal catalog descriptor rather than a standardized scientific nomenclature, with composition varying by formulator .

Each component targets a distinct phase of the repair cascade, with KPV providing the differentiating factor: dedicated anti-inflammatory modulation via NF-κB inhibition .

Each vial contains lyophilized powder tested to ≥99% purity per component by HPLC, with identity confirmed by mass spectrometry. A lot-specific Certificate of Analysis (COA) is available upon request.

Best for: Inflammatory pathway research, tissue repair studies, wound healing investigations, and regenerative medicine applications requiring expanded inflammation modulation.

Component Breakdown

KLOW vs. GLOW: The Distinction

KLOW is the four-peptide version that adds KPV to the GLOW formulation :

The addition of KPV makes KLOW more appropriate for research contexts where inflammation is a limiting factor . KPV downregulates pro-inflammatory cytokines, reduces NF-κB signaling, and promotes immune tolerance .

Mechanism of Action

The Four-Phase Repair Cascade :

1. Repair Signal (BPC-157): Upregulates growth hormone receptors, modulates nitric oxide signaling, promotes angiogenesis 

2. Infrastructure (TB-500): Sequesters G-actin, controls filament formation, enables repair cell migration to injury sites 

3. Remodeling (GHK-Cu): Stimulates collagen and elastin synthesis, modulates matrix metalloproteinases, provides antioxidant defense 

4. Inflammation Control (KPV): Inhibits NF-κB, reduces pro-inflammatory cytokines (IL-6, TNF-β, IL-1β), modulates immune response 

KPV’s Role: Where BPC-157 and TB-500 reduce localized inflammation as a side effect of their primary regenerative actions, KPV acts as the dedicated anti-inflammatory driver . This is particularly relevant for research contexts with a significant inflammatory load.

Specifications

Reconstitution Guidance

Reconstitute KLOW blend with bacteriostatic water (0.9% benzyl alcohol) for research use. Direct diluent gently down the inner wall of the vial rather than onto the lyophilized cake. Swirl slowly until fully dissolved — do not shake.

For best results, aliquot the reconstituted solution into single-use tubes immediately to avoid repeated freeze-thaw cycles.

Storage & Stability

Before Reconstitution: Store the unopened, lyophilized vial at −20°C in a desiccated, light-protected environment. Stable under these conditions for the shelf-life indicated on the certificate of analysis.

After Reconstitution: Store working solutions at 2–8°C for short-term use (up to 7-14 days). For long-term storage, prepare single-use aliquots and freeze at −20°C. Avoid repeated freeze-thaw cycles.

Quality Assurance

Every lot of KLOW undergoes comprehensive release testing against internal specifications, including:

• HPLC for purity confirmation per component (≥99%)

• Mass spectrometry for identity verification of each peptide

• Visual inspection of vial integrity

• Endotoxin screening (LAL test)

Each vial is coded with a lot number that links directly to release testing documentation. A lot-specific Certificate of Analysis (COA) is available upon request .

Important Research Notes

Not a Single Defined Product: KLOW is an informal term used across various sources. The exact composition can vary by formulator, and it is not part of standardized scientific nomenclature . Some sources define it as GLOW + KPV, while others describe it generally as a four-peptide blend .

No Published Clinical Trials for the KLOW Combination: No peer-reviewed clinical trials have tested this specific four-peptide combination. The synergy is mechanistically derived from individual component data .

Regulatory Context: BPC-157 and TB-500 are listed on the WADA Prohibited List. BPC-157 is not a dietary ingredient and is not approved for human clinical use .

Related Products from Pyrex Labs

Researchers who order KLOW frequently also purchase individual components for comparative studies:

• GLOW Blend – GHK-Cu + BPC-157 + TB-500 (three-peptide formulation)

• GHK-Cu – Individual copper peptide

• BPC-157 – Individual tissue repair peptide

• TB-500 – Individual thymosin beta-4 fragment

• KPV – Individual anti-inflammatory tripeptide

Frequently Asked Questions

What is KLOW? KLOW is a four-peptide blend containing GHK-Cu, BPC-157, TB-500, and KPV. It extends the GLOW formulation with the addition of KPV for dedicated anti-inflammatory modulation .

How is KLOW different from GLOW? GLOW contains three peptides (GHK-Cu, BPC-157, TB-500). KLOW adds KPV as a fourth component, expanding the research focus to include enhanced inflammation modulation .

What does KPV do in the blend? KPV is a tripeptide that inhibits NF-κB, reduces pro-inflammatory cytokines, and modulates immune response. It serves as the dedicated anti-inflammatory driver in the KLOW formulation .

Has the KLOW combination been studied in clinical trials? No. There are no published human clinical trials on this specific four-compound combination. The synergy is mechanistically coherent and extrapolated from component-level research .

Is KLOW approved for human use? No. This product is for research purposes only and is not FDA-approved for human consumption, medical treatment, or veterinary applications. BPC-157 and TB-500 are on the WADA Prohibited List .

Do you provide a Certificate of Analysis? Yes. A lot-specific COA is available upon request for every vial shipped, including HPLC purity data and mass spectrometry confirmation for each component.

Disclaimer

⚠️ FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN USE.

Not approved by the FDA. Not intended for diagnostic, therapeutic, or medical applications in humans or animals. BPC-157 and TB-500 are listed on the WADA Prohibited List. For in-vitro laboratory research exclusively. Pyrex Labs products are intended solely for scientific investigation and research purposes by qualified professionals.